EE738 Economic Value of Dupilumab and Advanced Therapeutics in Patients With Type 2 Inflammatory Diseases in Italy: An Estimation of Healthcare Resource Utilization Cost Offsets
Abstract
Authors
G Furneri J Tavi F Joulain Bego Le Bagousse G L Dreyfus Z Wang A Kuznik M Dobreva L Fourrier WH Cheng